Company Overview
About Delineate
Delineate is a United States-based AI clinical trial design and biomedical data extraction company — providing pharmaceutical companies, academic research teams, and contract research organizations (CROs) with AI-powered systematic review automation that accelerates the data extraction and evidence synthesis workflows critical for designing better, faster clinical trials in the $10 billion clinical trial design and data services market. Partnered with two top-10 global pharmaceutical companies, Delineate has performed some of the largest systematic-review studies ever conducted in drug development, delivering 15x more processed studies than industry standard timelines and reducing certain study completion times from months to weeks through AI models that extract and analyze data from biopharma research papers, patents, and regulatory documents at scale.
Business Model & Competitive Advantage
Delineate's AI data extraction platform combines custom large language models with computer vision models trained specifically for biomedical literature: the clinical trial design process requires synthesizing evidence from hundreds to thousands of existing clinical studies to understand what treatment arms, dosing regimens, patient populations, and endpoints have already been tested — a systematic review process that traditionally requires teams of PhD-level researchers spending months manually extracting data tables, adverse event rates, efficacy outcomes, and patient criteria from papers. Critically, much of this data is "trapped" in figures and plots (bar charts of efficacy results, Kaplan-Meier survival curves, dose-response graphs) rather than in machine-readable tables — Delineate's computer vision models extract quantitative data from these visual formats with the accuracy required for clinical evidence synthesis. The rigorous quality control processes (automated consistency checks, uncertain extraction flagging for human review) address the clinical-grade accuracy requirements that pharmaceutical companies apply to evidence used for regulatory submissions.
Competitive Landscape 2025–2026
In 2025, Delineate competes in the AI clinical trial design, systematic review automation, and biopharma data extraction market with Sciome (computational toxicology and systematic review, NIH-contracted), Elsevier's Reaxys (scientific data extraction, RELX group), and Scite (AI citation analysis for scientific literature, $7M raised) for pharmaceutical company clinical evidence synthesis and trial design support. The systematic review and meta-analysis market has been one of the highest-value AI application areas in pharmaceutical R&D — the evidence synthesis step that informs trial design decisions (what comparator to use, what endpoint is most sensitive, what dose range to test) has historically been the most labor-intensive and time-consuming pre-clinical research activity. Top-10 pharma partnerships validate Delineate's clinical-grade accuracy for the high-stakes drug development workflows where errors in evidence synthesis could lead to suboptimal trial designs and significant capital waste. The 2025 strategy focuses on expanding the pharmaceutical company partnerships for late-phase trial design support, building the regulatory evidence package automation for NDA and BLA submissions, and growing the platform into real-world evidence (RWE) data extraction from electronic health records.
Recent Activity
View all →As part of our Delineate Community Commitment, we are proud to celebrate the recipients of our Spring 2026 community grant funding […]
Material Event filed 2026-09-24
The membership is another step in our expansion across the region and reflects our continued focus on research quality, innovation […]
The Challenge Johnsonville is the leading sausage brand in the United States, a family-owned company founded in 1945 and now […]
Most brand tracker evaluations focus on the parts that are easy to inspect. Buyers scrutinize sample composition, metric definitions, question […]
What Delineate heard at the 2026 Future of Insights Summit, from AI and synthetic respondents to brand tracking frustrations and […]
Three subjects dominated our booth conversations at the Javits Center. The more we heard, the clearer it became that they’re tangled […]
Quarterly Report filed 2026-08-05
Material Event filed 2026-08-05
Delineate has joined Vertus Group, a division of Jonas Software, marking an exciting new chapter for the business. Delineate gives […]
AI will change the work of insights teams, but it may also change something less visible: how people learn to […]
A jointly built integration puts verified respondent sourcing across 130+ markets behind Delineate Proximity®, the always-on consumer intelligence platform. Every […]
Company Timeline
Major milestones in Delineate's journey
Leadership Team
Meet the leaders behind Delineate
Emily Nieves
Jawad Iqbal
Key Differentiators
Emerging Innovator
Delineate is an emerging player bringing innovative solutions to the Healthcare Tech market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Pfizer
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan
Moderna
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép
Amgen
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Doximity
Doximity is a professional network and digital health platform purpose-built for licensed physicians and other healthcare professionals in the United States. With more than two million verified clinic
Zocdoc
Zocdoc operates a two-sided marketplace connecting patients with physicians, dentists, and mental health providers who accept their specific insurance and have real-time appointment availability. Pati
Compare Delineate with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Delineate? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Delineate Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Delineate vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →